165 related articles for article (PubMed ID: 27649524)
1. Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability.
Piper T; Schänzer W; Thevis M
Drug Test Anal; 2016 Nov; 8(11-12):1163-1173. PubMed ID: 27649524
[TBL] [Abstract][Full Text] [Related]
2. Epiandrosterone sulfate prolongs the detectability of testosterone, 4-androstenedione, and dihydrotestosterone misuse by means of carbon isotope ratio mass spectrometry.
Piper T; Putz M; Schänzer W; Pop V; McLeod MD; Uduwela DR; Stevenson BJ; Thevis M
Drug Test Anal; 2017 Nov; 9(11-12):1695-1703. PubMed ID: 28836353
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.
Miller GD; Nair V; Morrison MS; Summers M; Willick SE; Eichner D
Drug Test Anal; 2016 Nov; 8(11-12):1197-1203. PubMed ID: 27714988
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios.
Anielski P; Simmchen J; Wassill L; Ganghofner D; Thieme D
Drug Test Anal; 2011 Oct; 3(10):645-51. PubMed ID: 21928278
[TBL] [Abstract][Full Text] [Related]
5. UDP-glucuronosyltransferase 2B17 genotyping in Japanese athletes and evaluation of the current sports drug testing for detecting testosterone misuse.
Okano M; Ueda T; Nishitani Y; Kano H; Ikekita A; Kageyama S
Drug Test Anal; 2013 Mar; 5(3):166-81. PubMed ID: 22887913
[TBL] [Abstract][Full Text] [Related]
6. Investigations on hydrogen isotope ratios of endogenous urinary steroids: reference-population-based thresholds and proof-of-concept.
Piper T; Thomas A; Thevis M; Saugy M
Drug Test Anal; 2012 Sep; 4(9):717-27. PubMed ID: 22991188
[TBL] [Abstract][Full Text] [Related]
7. Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests.
Schulze JJ; Lundmark J; Garle M; Ekström L; Sottas PE; Rane A
Steroids; 2009 Mar; 74(3):365-8. PubMed ID: 19056415
[TBL] [Abstract][Full Text] [Related]
8. Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation.
Schulze JJ; Lundmark J; Garle M; Skilving I; Ekström L; Rane A
J Clin Endocrinol Metab; 2008 Jul; 93(7):2500-6. PubMed ID: 18334593
[TBL] [Abstract][Full Text] [Related]
9. Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing.
Piper T; Emery C; Thomas A; Saugy M; Thevis M
Anal Bioanal Chem; 2013 Jun; 405(16):5455-66. PubMed ID: 23568614
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.
Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L
Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073
[TBL] [Abstract][Full Text] [Related]
11. Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids.
Aguilera R; Becchi M; Casabianca H; Hatton CK; Catlin DH; Starcevic B; Pope HG
J Mass Spectrom; 1996 Feb; 31(2):169-76. PubMed ID: 8799270
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two glucuronides resistant to enzymatic hydrolysis as markers of testosterone oral administration.
Kotronoulas A; Gomez-Gomez A; Segura J; Ventura R; Joglar J; Pozo OJ
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):212-218. PubMed ID: 27328448
[TBL] [Abstract][Full Text] [Related]
13. Sensitive detection of testosterone and testosterone prohormone administrations based on urinary concentrations and carbon isotope ratios of androsterone and etiocholanolone.
Piper T; Haenelt N; Fusshöller G; Geyer H; Thevis M
Drug Test Anal; 2021 Nov; 13(11-12):1835-1851. PubMed ID: 34648228
[TBL] [Abstract][Full Text] [Related]
14. Discordant genotyping results using DNA isolated from anti-doping control urine samples.
Choong E; Schulze JJ; Ericsson M; Rane A; Ekström L
Drug Test Anal; 2017 Jul; 9(7):994-1000. PubMed ID: 27706926
[TBL] [Abstract][Full Text] [Related]
15. Recent developments in the use of isotope ratio mass spectrometry in sports drug testing.
Piper T; Emery C; Saugy M
Anal Bioanal Chem; 2011 Aug; 401(2):433-47. PubMed ID: 21448602
[TBL] [Abstract][Full Text] [Related]
16. Optimization of an online heart-cutting multidimensional gas chromatography clean-up step for isotopic ratio mass spectrometry and simultaneous quadrupole mass spectrometry measurements of endogenous anabolic steroid in urine.
Casilli A; Piper T; de Oliveira FA; Padilha MC; Pereira HM; Thevis M; de Aquino Neto FR
Drug Test Anal; 2016 Nov; 8(11-12):1204-1211. PubMed ID: 27739243
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen isotope ratio mass spectrometry and high-resolution/high-accuracy mass spectrometry in metabolite identification studies: detecting target compounds for sports drug testing.
Thevis M; Piper T; Horning S; Juchelka D; Schänzer W
Rapid Commun Mass Spectrom; 2013 Sep; 27(17):1904-12. PubMed ID: 23939956
[TBL] [Abstract][Full Text] [Related]
18. Carbon isotope ratio determination and investigation of seized testosterone preparations.
Forsdahl G; Östreicher C; Koller M; Gmeiner G
Drug Test Anal; 2011; 3(11-12):814-9. PubMed ID: 22102298
[TBL] [Abstract][Full Text] [Related]
19. Degradation of urine samples and its influence on the ¹³C/¹²C ratios of excreted steroids.
Piper T; Geyer H; Schänzer W
Drug Test Anal; 2010; 2(11-12):620-9. PubMed ID: 21204293
[TBL] [Abstract][Full Text] [Related]
20. 13C/12C ratios of endogenous urinary steroids investigated for doping control purposes.
Piper T; Flenker U; Mareck U; Schänzer W
Drug Test Anal; 2009 Feb; 1(2):65-72. PubMed ID: 20355178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
